Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
05/29/2008 | CA2661172A1 Programmable buoyant delivery technology |
05/29/2008 | CA2657829A1 Particles for delivery of active ingredients, process of making and compositions thereof |
05/28/2008 | EP1925324A1 Hydrogel Adhesives for Use on Hair or Fiber-Populated Surfaces |
05/28/2008 | EP1925319A1 Pharmaceutical compositions containing sc(fv)2 |
05/28/2008 | EP1925308A1 Low hygroscopic aripiprazole (crystal G) drug substance and processes for the preparation thereof |
05/28/2008 | EP1925300A2 Adhesive preparation |
05/28/2008 | EP1925299A1 Adhesive patch less irritative to skin |
05/28/2008 | EP1925298A1 Highly inhibited starch fillers for films and capsules |
05/28/2008 | EP1925297A1 Method for preparing microparticles having a selected polymer molecular weight |
05/28/2008 | EP1925296A1 Stable powder formulation containing a new antichinolinergic agent |
05/28/2008 | EP1925295A1 Stable powder formulation containing a new antichinolinergic agent |
05/28/2008 | EP1925294A1 Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrients |
05/28/2008 | EP1925293A2 Pharmaceutical aerosol compositions |
05/28/2008 | EP1924291A2 Factor xa inhibitor inclusion complex with cyclodextrin |
05/28/2008 | EP1924289A2 Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents |
05/28/2008 | EP1924269A2 Vegetation water composition for treatment of inflammatory skin conditions |
05/28/2008 | EP1924261A1 Stable solid formulation of sertindole |
05/28/2008 | EP1924258A1 IMPROVED PHARMACEUTICAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR AND METHOD FOR THE PREPARATION THEREOF |
05/28/2008 | EP1924251A1 Topical formulations containing o-desmethyl venlafaxine (odv) or its salts |
05/28/2008 | EP1924249A2 Transdermal drug delivery devices containing o-desmethyl venlafaxine (odv) or its salts |
05/28/2008 | EP1924248A1 Ph sensitive nanoparticle formulation for oral delivery of proteins/peptides |
05/28/2008 | EP1924247A2 Liposome compositions |
05/28/2008 | EP1924246A2 Sachet formulation for amine polymers |
05/28/2008 | EP1924245A2 Topical formulations of histone deacetylase inhibitors and methods of using the same |
05/28/2008 | EP1924244A2 Magnetic-field controlled active substance transfer for aerosol therapy |
05/28/2008 | EP1924243A1 Prolonged release formulations comprising anastrozole |
05/28/2008 | EP1924242A1 Formulation |
05/28/2008 | EP1924209A2 Methods and devices for delivering agents across biological barriers |
05/28/2008 | EP1924156A2 Encapsulated active ingredients, methods of preparation and their use |
05/28/2008 | EP1924151A2 Controlled release oral delivery systems |
05/28/2008 | EP1741425B1 Novel antiviral pharmaceutical composition |
05/28/2008 | EP1699446B1 Compositions and methods for treating hepatitis c virus (hcv) infection |
05/28/2008 | EP1663162B1 Orally administrable dosage form for poorly soluble acids and amphoteric active ingredients |
05/28/2008 | EP1620069B1 Warming and nonirritating lubricant fungicide compositions in the form of a gel |
05/28/2008 | EP1617814B1 Method for the dispersion of water-soluble or hydrophilic substances in a supercritically pressurized fluid |
05/28/2008 | EP1592405B1 Composition for chemoembolotherapy of solid tumors |
05/28/2008 | EP1578406B1 Modified release pharmaceutical composition |
05/28/2008 | EP1534253B1 Process for making orally consumable dosage forms |
05/28/2008 | EP1494992B1 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
05/28/2008 | EP1471895B1 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
05/28/2008 | EP1467769B1 Use of a resinate in the preparation of a formulation for smoking cessation |
05/28/2008 | EP1450773B1 Transdermal therapeutic system provided with improved long-term carrying comfort |
05/28/2008 | EP1438072B1 Polysaccharide-based network and method for the production thereof |
05/28/2008 | EP1368063B1 Complex of modafinil and cyclodextrin |
05/28/2008 | EP1343483B1 Transdermal system containing a novel high potency progestagen |
05/28/2008 | EP1343476B1 Preparation of large liposomes by infusion into peg |
05/28/2008 | EP1325035B1 Pharmaceutically acceptable starch and manufacturing process thereof |
05/28/2008 | EP1322595B1 (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents |
05/28/2008 | EP1277471B1 Stable liquid preparation comprising sitafloxacin |
05/28/2008 | EP1087752B1 Method for producing liposomal formulations of active agents |
05/28/2008 | EP1009759B1 Carbohydrate crosslinked glycoprotein crystals |
05/28/2008 | EP1005485B1 Therapeutic pulmonary lavage with diluted surfactants |
05/28/2008 | EP0968711B9 Dermatological patch sheet and process for producing base sheet therefor |
05/28/2008 | CN201064622Y Ion leading-in medicine label convenient for storing and carrying |
05/28/2008 | CN201064559Y Black plaster quantitatively coating and film-laying integrated machine |
05/28/2008 | CN201064168Y Oligomeric proanhocyanidins microcapsule |
05/28/2008 | CN101189339A Delivery systems and methods for diagnosing and treating cardiovascular diseases |
05/28/2008 | CN101189031A Method for terminal sterilization of transdermal delivery devices |
05/28/2008 | CN101189030A Method for terminal sterilization of transdermal delivery devices |
05/28/2008 | CN101189029A Pharmaceutical dosage forms comprising a lipid phase |
05/28/2008 | CN101189016A Device and methods for treating paranasal sinus conditions |
05/28/2008 | CN101189001A Aerosol and injectable formulations of nanoparticulate benzodiazepine |
05/28/2008 | CN101189000A Device for delivery of TRPV1 agonists |
05/28/2008 | CN101188999A A pharmaceutical delivery system for deliverying active component dispersed in dispersion medium |
05/28/2008 | CN101188998A Personal lubricant containing polyethylene oxide |
05/28/2008 | CN101188997A Blends of inactive particles and active particles |
05/28/2008 | CN101188996A Surface-modified microparticles and methods of forming and using the same |
05/28/2008 | CN101188989A Microimplants for ocular administration |
05/28/2008 | CN101186936A Method for producing dry bacterium powder containing gamma-linolenic acid |
05/28/2008 | CN101186612A Pyrroline derivative capable of inhibiting cell to release tumor necrotic factor and its preparation and application |
05/28/2008 | CN101185868A Technique for preparing lomoxicam ultra-fine particles using by supercritical fluid crystallization technology |
05/28/2008 | CN101185761A Ephedrine hydrochloride cyclodextrin inclusion compound and its granule preparation method |
05/28/2008 | CN101185759A Anti-angiogene compositions and methods of use |
05/28/2008 | CN101185751A Traditional Chinese medicine oral liquid for treating diarrhea and its manufacturing method |
05/28/2008 | CN101185750A Medicine bag for treating hyperosteogeny |
05/28/2008 | CN101185743A Ointment shape medicament for treating soft tissue contusion |
05/28/2008 | CN101185738A Gynaecologic inflammation rehabilitation effervescence granular preparation and confecting method thereof |
05/28/2008 | CN101185734A Traditional Chinese medicine for treating chronic diarrhea and its manufacturing method |
05/28/2008 | CN101185733A Jianweixiaoshi orally disintegrating tablets and preparation method |
05/28/2008 | CN101185727A Traditional Chinese medicine preparation containing ginseng and pilose antler capable of nourishing heart and nourishing kidney |
05/28/2008 | CN101185721A Paste medicine for treating acute periodontitis |
05/28/2008 | CN101185719A Medicinal composition for treating rhinitis and nasosinusitis |
05/28/2008 | CN101185718A Medicine for treating bone joint disease and its preparation method |
05/28/2008 | CN101185717A Traditional Chinese medicine for treating acute chronic gastroenteritis and intestine gastric ulcer |
05/28/2008 | CN101185716A Proprietary Chinese medicine for treating gastropathy |
05/28/2008 | CN101185713A Medicine preparation for treating traumatic injuries and its preparation method and quality control method |
05/28/2008 | CN101185711A Nucleus eliminating ointment special for treating hyperplasia of mammary glands |
05/28/2008 | CN101185710A Powder agent medicine for treating chronic otitis media suppurative |
05/28/2008 | CN101185708A Powder agent medicine for treating acute otitis media suppurative |
05/28/2008 | CN101185707A Antiphlogistic antiviral medicinal composition, and its preparation method and application |
05/28/2008 | CN101185706A Hippophae rhamnoides nutrition mixture with delaying senility function and preparation technique thereof |
05/28/2008 | CN101185705A Cream shape medicine for treating impetigo |
05/28/2008 | CN101185704A Powder agent medicine for treating aphtha |
05/28/2008 | CN101185696A Cream shape medicine for treating II or III degree bedsore |
05/28/2008 | CN101185694A Powder agent medicine for treating infantile thrush |
05/28/2008 | CN101185693A New use of scyphiphora hydrophyllacea and its extract in preparing anti-liver-cancer medicine |
05/28/2008 | CN101185691A Powder agent medicine for treating infantile aphtha |
05/28/2008 | CN101185690A Medicine for preventing and overcoming climate sickness |
05/28/2008 | CN101185686A Powder agent medicine for treating eczema |
05/28/2008 | CN101185683A Cream shape medicine for treating infantile sweatful symptoms |